NPO Insider Filing: Robert McLean Reports 3,700 Options and 924-Share Disposition
Rhea-AI Filing Summary
Form 4 summary
Reporting person Robert S. McLean (EVP, GC, and CAO) filed a Form 4 for Enpro Inc. (NPO) reporting transactions dated 08/07/2025 (signed 08/08/2025). Table I shows an acquisition of 3,700 common shares at $53.78 and a disposition of 924 common shares at $215.50. Reported beneficial ownership following the transactions is listed as 32,811 and 31,887 shares (direct). Table II reports 3,700 stock options with a conversion/exercise price of $53.78, a reported derivative price of $0.0000, and 7,490 derivative securities beneficially owned following the transactions. The form includes a vesting schedule (equal thirds on 2/27/2021, 2/27/2022 and 2/27/2023) and an expiration date of 2/27/2030.
Positive
- Detailed disclosure of option vesting schedule and expiration date (2/27/2030) is included
- Reporting person retains direct ownership in the tens of thousands of shares (reported 31,887–32,811 shares)
Negative
- Insider disposition of 924 shares on 08/07/2025 at $215.50 is reported
Insights
TL;DR: Insider reported both an option grant/derivative position and a small open-market sale; net position increased by the reported amounts.
The filing documents same-day activity on 08/07/2025: an entry showing 3,700 common shares associated with a $53.78 price and a separate 924-share disposition at $215.50. Table II lists 3,700 stock options at a conversion/exercise price of $53.78 and a derivative security price of $0.0000, with 7,490 derivative securities reported post-transaction. This is a routine Section 16 disclosure of insider holdings and option-related transactions; the filing itself provides no company guidance or valuation commentary.
TL;DR: Form 4 shows executive-level transactions and option-related holdings; disclosure appears complete with vesting and expiration details.
The report identifies Robert S. McLean as EVP, GC, and CAO and includes a vesting schedule for the referenced options (equal thirds on 2/27/2021, 2/27/2022, 2/27/2023) and an expiration date of 2/27/2030. Signature and filing metadata are present. The filing does not disclose the purpose of the transactions beyond the tabulated entries; no additional governance actions are reported.